Skip to Content

IG 302 (Alfuzosin hydrochloride extended-release 10 mg)

Pill imprint IG 302 has been identified as Alfuzosin hydrochloride extended-release 10 mg.

Alfuzosin is used in the treatment of benign prostatic hyperplasia and belongs to the drug class antiadrenergic agents, peripherally acting. There is no proven risk in humans during pregnancy. Alfuzosin 10 mg is not a controlled substance under the Controlled Substance Act (CSA).

Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release 10 mg IG 302 Front
Alfuzosin hydrochloride extended-release 10 mg IG 302 Back
Alfuzosin hydrochloride extended-release 10 mg IG 302
Alfuzosin hydrochloride extended-release
Imprint:
IG 302
Strength:
10 mg
Color:
White
Shape:
Round
Availability:
Prescription only
Drug Class:
Antiadrenergic agents, peripherally acting
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Manufacturer:
Invagen Pharmaceuticals

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide